T-Mobile and Gilead Sciences Earn Buy Upgrades, Pfizer and Datadog Cut

AnalystDigital Finance
โดย 24/7 Wall St.·Read original
Summary · why it matters

T-Mobile and Gilead Sciences both received Buy upgrades on Monday, with Bank of America setting a $220 target on T-Mobile and HSBC setting a $155 target on Gilead. Pfizer was downgraded to Hold from Buy at HSBC, which trimmed its target to $28 from $32, while Datadog was cut to Market Perform from Outperform at Bernstein, though its target was raised to $226 from $180. Among other notable calls, Agnico Eagle Mines was upgraded to Buy at Jefferies with a $200 target, Okta was raised to Outperform at Scotiabank with a $165 target, and Delta Air Lines was cut to Outperform from Strong Buy at Raymond James with a target lifted to $104 from $80. New initiations included ERock with Outperform ratings from Evercore ISI and JPMorgan at a $28 target, and Glaukos with a Buy rating at H.C. Wainwright and a $168 target.

Impact on stocks 17

Cloud & Digital Infrastructure± Mixed · 3 stocks
Datadog Inc
DDOG
▼ NegativeCapitalrelevance

Downgraded to Market Perform from Outperform at Bernstein.

T-Mobile US Inc
TMUS
▲ PositiveCapitalrelevance

T-Mobile received a Buy upgrade from Bank of America with a $220 target.

Biotech & Genomic Medicine± Mixed · 3 stocks
Pfizer Inc
PFE
▼ NegativeCapitalrelevance

Pfizer was downgraded to Hold from Buy at HSBC, which trimmed its target to $28 from $32.

Financials▲ · 3 stocks
Industrials▼ · 2 stocks
Critical Materials & Supply Chain▲ · 1 stocks
Aging Population▲ · 1 stocks
Glaukos Corp
GKOS
▲ PositiveCapitalrelevance

Initiated with Buy at H.C. Wainwright and a $168 target.

Cybersecurity & Digital Trust▲ · 1 stocks
Okta Inc
OKTA
▲ PositiveCapitalrelevance

Okta was upgraded to Outperform at Scotiabank with a $165 target.

Energy Transition & Power Demand▲ · 1 stocks
Energy▲ · 1 stocks
Others▲ · 1 stocks
ERock, Inc.
EROC
▲ PositiveCapitalrelevance

ERock was initiated with Outperform ratings from Evercore ISI and JPMorgan at a $28 target.

© 2026 MarketDXNews